About the Kidney Cancer Session
Kidney cancer research has made significant strides, focusing on understanding the genetic and molecular underpinnings of the disease. Studies have identified key mutations and pathways, such as alterations in the VHL gene and the mTOR signaling pathway, which drive cancer progression. This has led to the development of targeted therapies, including tyrosine kinase inhibitors and immune checkpoint inhibitors, which have improved survival rates and outcomes for patients. Ongoing research is exploring combination treatments and personalized medicine approaches to enhance efficacy and reduce side effects. Additionally, advancements in imaging and diagnostic techniques are enabling earlier detection and more precise staging of kidney cancer, further contributing to improved patient management and prognosis.
Topics Covered in Kidney Cancer
Clear Cell Carcinoma
Non-Clear Cell Subtypes
VHL Pathway
Small Renal Masses
Nephron-Sparing Surgery
Checkpoint Combinations
Related Scientific Sessions at CIOC 2027
Why Attend the Kidney Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Kidney Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Kidney Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Kidney Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Kidney Cancer Conference 2027 — FAQs
What is the Kidney Cancer track at CIOC 2027?
The Kidney Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Kidney Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Kidney Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Kidney Cancer are all welcome — whether presenting or attending.
Can I present my research in the Kidney Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Kidney Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Kidney Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.